StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.30−0.09 (-2.65%)

Close on Nov 16, 2026Market cap $28.82MP/E –Yield –

BriaCell Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BriaCell Therapeutics's enterprise value was $9.88M on Nov 11, 2026, against -$7.84M a year earlier. Over the last 5 years it ranged from -$25.21M to $93.83M, with a median of $16.80M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.88M–
2025Nov 28, 2025-$82.67K-100.6%
2024Dec 31, 2024$14.32M-82.0%
2023Dec 29, 2023$79.64M+159.1%
2022Dec 30, 2022$30.74M-56.0%
2021Dec 31, 2021$69.87M+2250.9%
2020Dec 31, 2020$2.97M–

More BriaCell Therapeutics figures

See a number that looks wrong?